Gut Microbiome: Profound Implications for Diet and Disease.

Hills RD, Pontefract BA, Mishcon HR, Black CA, Sutton SC, Theberge CR. · 2019

Read Gut Microbiome: Profound Implications for Diet and Disease. by Hills RD, Pontefract BA, Mishcon HR, Black CA, Sutton SC, Theberge CR. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6682904.txt.

Introduction

Hills and co-authors review the gut microbiome and what it means for diet and disease. Their review appears in Nutrients. Gut bacteria shape many chronic conditions. Metabolic disease, gut disorders, and colorectal cancer feature. Diet shapes the microbial community in real time. Fibre fermentation yields short-chain fatty acids. Those signals support lipid balance and calm inflammation. A person's starting gut profile predicts probiotic response. Enterotypes sum up community patterns across people.

The review covers diet quality in depth. Carbohydrate intake, FODMAPs, and prebiotic fibre get sections. Western diets reduce diversity over time. Effects span obesity and diabetes. Irritable bowel and inflammatory bowel disease follow. Depression and heart vessel disease close the survey. The gut emerges as a diet-shaped organ.

Catalog record

CREATORHills RD, Pontefract BA, Mishcon HR, Black CA, Sutton SC, Theberge CR.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE169 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6682904

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Gut Microbiome: Profound Implications for Diet and Disease By Ronald D Hills, Benjamin A Pontefract, Hillary R Mishcon, Cody A Black, Steven C Sutton, Cory R Theberge Published in: Nutrients DOI: 10.3390/nu11071613 ABSTRACT Abstract The gut microbiome plays an important role in human health and influences the development of chronic diseases ranging from metabolic disease to gastrointestinal disorders and colorectal cancer. Of increasing prevalence in Western societies, these conditions carry a high burden of care. Dietary patterns and environmental factors have a profound effect on shaping gut microbiota in real time. Diverse populations of intestinal bacteria mediate their beneficial effects through the fermentation of dietary fiber to produce short-chain fatty acids, endogenous signals with important roles in lipid homeostasis and reducing inflammation. Recent progress shows that an individual’s starting microbial profile is a key determinant in predicting their response to intervention with live probiotics. The gut microbiota is complex and challenging to characterize. Enterotypes have been proposed using metrics such as alpha species diversity, the ratio of Firmicutes to Bacteroidetes phyla, and the relative abundance of beneficial genera (e.g., Bifidobacterium, Akkermansia) versus facultative anaerobes (E. coli), pro-inflammatory Ruminococcus, or nonbacterial microbes. Microbiota composition and relative populations of bacterial species are linked to physiologic health along different axes. We review the role of diet quality, carbohydrate intake, fermentable FODMAPs, and prebiotic fiber in maintaining healthy gut flora. The implications are discussed for various conditions including obesity, diabetes, irritable bowel syndrome, inflammatory bowel disease, depression, and cardiovascular disease. Keywords: gut microbiota, nutrition, habitual diets, Western diet, obesity, cardiometabolic risk factors, chronic health conditions, gastrointestinal disorders, prebiotics and probiotics 1. INTRODUCTION TO GUT MICROBIOTA AND DISEASE The intestinal microbiome has recently been implicated in a host of chronic diseases ranging from inflammatory bowel disease (IBD), type 2 diabetes (T2D), and cardiovascular disease (CVD) to colorectal cancer [1,2,3]. The community of ~200 prevalent bacteria, virus, and fungi inhabiting the human gastrointestinal (GI) tract provide unique metabolic functions to the host and are fundamentally important in health and disease [4,5]. Microbiome refers to the collective genomes of all microorganisms inhabiting an environment. While isolating and culturing each individual species is an intractable task, a cutting-edge method of sequence analysis, metagenomics, has enabled the reconstruction of microbial species and their function from the collective nucleotide contents contained in a stool sample. Shotgun metagenomic sequencing analysis discovered 1952 unclassified bacteria species in the human gut microbiome in addition to the 553 bacteria previously cultured from the gut [6]. A central question in medicine concerns the nature of the relationship between human health and the gut microbiota, which refers to the community of microorganisms themselves, the relative abundance of individual species populations, and their function. Metagenomics and analysis of twins data has revealed that environmental factors such as diet and household cohabitation greatly outweigh heritable genetic contributions to the composition and function of gut microbiota [7]. Analogous to the genetic heritability statistic, Rothschild et al. constructed a microbiome-association index. Significant associations are observed between the gut microbiome and host phenotypes for body mass index (BMI) (25%), waist-to-hip ratio (24%), fasting glucose levels (22%), glycemic status (25%), high-density lipoprotein (HDL) cholesterol levels (36%), and monthly lactose consumption (36%) [7]. Compared to BMI, waist-to-hip ratio is an anthropometric measurement of central obesity and stronger predictor of diastolic and systolic blood pressure, total cholesterol/HDL, and triglycerides [8] as well as death from CVD [9]. The Western diet has profound effects on the diversity and populations of microbial species that make up gut flora [10]. The U.S. is home to the largest number of immigrants in the world, many of whom develop metabolic diseases post immigration. Earlier epidemiological evidence revealed a fourfold increase in obesity risk is possible within 15 years of emigrating to the U.S. compared to populations remaining in their birth country [11]. In a recent cross-sectional and longitudinal study of a multi-generational Asian American cohort, emigrating to the U.S. was shown to reduce gut microbial diversity and function [12]. Alpha diversity was measured using the Shannon entropy, a quantitative index that accounts for the abundance and evenness of species residing in the host, as opposed to species richness, which is the number of species present. Within the gram-negative Bacteroidetes phylum, bacterial strains from the genus Prevotella, whose enzymes degrade plant fiber, became displaced by dominant strains from the genus Bacteroides according to an individual’s time spent in the U.S. The ratio of Bacteroides to Prevotella increased by factors of 10, correlating with the time in decades spent in the U.S. Prior to this study, metagenomics had identified three clusters of variation in the human gut, referred to as enterotypes [13]. The first enterotype, high in Bacteroides and low in Prevotella, is found in individuals on a long-term Western diet high in animal protein, the nutrient choline, and saturated fat [14]. The second enterotype is high in Prevotella, low in Bacteroides, and associated with a plant-based diet rich in fiber, simple sugars, and plant-derived compounds. While less distinct, a third potential enterotype was found with a slightly higher population of genus Ruminococcus within the phylum Firmicutes. Enriched Ruminococcus is associated with irritable bowel syndrome (IBS) [15], and transient blooms of pro-inflammatory Ruminococcus have been associated with active flare-ups in IBD [16]. R. gnavus, a prevalent gut microbe that proliferates in IBD, has been found to secrete a unique L-rhamnose oligosaccharide that induces tumor necrosis factor alpha (TNFα), a major pro-inflammatory cytokine [17]. 2. MICROBIOTA, THE IMMUNE RESPONSE, AND DIET IN IBD IBD is a chronic GI disorder characterized by an overactive immune response to the gut microbiome. A serious, debilitating condition, IBD affects growth and development in children, increases the risk of colorectal cancer, and can lead to life-threatening complications [18]. There are two forms of IBD, Crohn’s disease and ulcerative colitis, that differ in the inflamed areas of the intestine. Normally, anaerobic microbes in the gut derive their nutrients from fermentation of indigestible oligosaccharides and other carbohydrates escaping proximal digestion [19]. In IBD, respiratory electron acceptors generated as a byproduct of the inflammatory host response become environmental stressors that support bacterial growth [20]. The disorder results in oxidative stress for the host and the microbiome, leading to gut dysbiosis in the form of decreased community richness and proliferation of facultative anaerobic Enterobacteriaceae and adherent invasive strains of Escherichia coli [16,20,21]. Drug therapies for IBD have traditionally included immunosuppressants in the form of corticosteroids, antimetabolite agents, or anti-TNF antibodies, often with ancillary administration of antibiotics [22]. An alternative treatment, given predominantly to children, is a defined enteral nutrition formula. Dietary therapy has the advantage of obviating the need for immunosuppression and is thought to work by altering the composition of gut microbiota. A longitudinal study involving metagenomic analysis was conducted of 90 children initiating treatment for Crohn’s disease [22]. GI symptoms, mucosal inflammation, and microbial communities were compared for dietary and anti-TNF therapy and antibiotic use relative to healthy children. Microbial communities separated into two clusters based on composition. The dysbiotic community associated with active disease was characterized by increased fungal representation, increased lactose-fermenting bacteria (Streptococcus, Lactobacillus, Klebsiella), and the presence of human DNA in the stool (from epithelial cells and white blood cells). Crohn’s patients also had reduced relative

Read the complete text